NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts
NCT00804830 2018-08-28Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid CancerRegion SkanePhase 2 Terminated15 enrolled